In stage III rectal cancer, R values were significant prognostic values in OS and DFS by multivariate analysis of prognostic factors, such as N-staging (P = 0.02, P = 0.002, respectively).
When we tested our prognostic model against the AJCC model in a multivariate analysis, the prognostic impact of our model based on neutrophils, LDH and performance status (P<0.001) was superior compared to the AJCC model (P=0.22).
Kern W, Schoch C, Haferlach T, Braess J, Unterhalt M, Wormann B. et al. Multivariate analysis of prognostic factors in patients with refractory and relapsed acute myeloid leukemia undergoing sequential high-dose cytosine arabinoside and mitoxantrone (S-HAM) salvage therapy: relevance of cytogenetic abnormalities.
Pretreatment factors were analyzed by univariate and multivariate analysis for prognostic significance for 5-year overall survival (OS), event-free survival (EFS), and progression-free survival (PFS .At a median follow-up of 4.2 years (range, 0.7 to 11.9 years), the 5-year OS, EFS, and PFS rates were 68%, 53%, and 63%, respectively.
Multivariate analysis of prognostic factors was performed using Cox proportional hazard model (Medcalc).
Univariate and multivariate analysis of prognostic associations for miR184 signature.
Multivariate analysis of prognostic factors was performed using the Cox proportional hazard model.
On multivariate analysis adverse prognostic factors were advanced age, incomplete resection and lymph node involvement.
However, in multivariate analysis, the prognostic significance of PLR was markedly diminished (Tables 2 and 3).
